Countdown to 2022 CBIIC：
Founder&CEO, Shenzhen HighTide Biopharmaceutical Ltd.
Liping Liu is the founder and CEO of HighTide, who is fully responsible for HighTide’s daily operation, fundraising, leading drug research and development, etc.She is a named inventor of an FDA approved diabetes drug and was involved with over 10 IND submissions and 100+ international patent applications and issuance. Through her extensive drug research and development experience, Dr. Liu has formed insights and perspectives on the complex etiology and pathogenesis of chronic liver, gastrointestinal and metabolic diseases. Dr. Liu received her doctoral degree from Nankai University in 1994, completed post-doctoral training in University of Toronto, and received MBA degree from Johns Hopkins University Carey Business School in 2006.Dr. Liu has received many awards in the industry and business circles, including “Top 15 Biotech Leaders” “2021 Top 30 Female Entrepreneurs to Watch” and “Top 10 Innovative Scientists” selected industry and business media.